AKT1 and diffuse large B-cell lymphoma: As MEK/ERK [38] and PI3K/AKT pathways [39] have been implicated as upstream activator of HIF-1α, it is conceivable that the HIF-1α suppressive effects of PCI-24781 in DLBCL cells are attributable to an interaction of the drug with an upstream kinase.